Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 213-220 , June 2002

Prevalence of latent autoimmune diabetes of adults (LADA) in Southern Spain

  • Diabetes Group of the Andalusian Society of Endocrinology and Nutrition
    • ,
  • Federico Soriguer-Escofet

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • Corresponding Author InformationCorresponding author. Present address: C/Chopera, 6 29018 Malaga, Spain. Tel./fax: +34-952-286704
    • ,
  • Isabel Esteva

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • ,
  • Gemma Rojo-Martinez

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • ,
  • Soledad Ruiz de Adana

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • ,
  • Marieta Catalá

      Affiliations

    • Cartama Health Centre, Malaga, Spain
    • ,
  • M.José Merelo

      Affiliations

    • Cartama Health Centre, Malaga, Spain
    • ,
  • Manuel Aguilar

      Affiliations

    • Endocrinology and Nutrition Section, Hospital Puerta del Mar, Cádiz, Spain
    • ,
  • Francisco Tinahones

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • ,
  • José M. Garcı́a-Almeida

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • ,
  • Juan M. Gómez-Zumaquero

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • ,
  • Antonio L. Cuesta-Muñoz

      Affiliations

    • Endocrinology and Nutrition Service, Hospital Civil, Carlos Haya Hospital Complex, Malaga, Spain
    • ,
  • José Ortego

      Affiliations

    • Endocrinology and Nutrition Section, Hospital Puerta del Mar, Cádiz, Spain
    • ,
  • José M. Freire

      Affiliations

    • Endocrinology and Nutrition Section, Hospital Puerta del Mar, Cádiz, Spain

Received 3 July 2001 ,Revised 24 November 2001 ,Accepted 20 December 2001.

References 

  1. Diamond JM. Human evolution: diabetes running wild. Nature. 1992;357:362–363
  2. Zimmet PZ. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity and demography. Diabetes Care. 1995;18:1050–1064
  3. Tuomi T, Carlsson A, Li H, Isomaa B. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999;48:150–157
  4. Rattarasarn C, Diosdado MAguilar. Clinical characteristic and time course of pancreatic cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset type 1 diabetes: distinction between patients of rapid- and slow-onset. Horm. Metab. Res. 1999;31:311–316
  5. Tamayo-Marco B, Faure-Nogueras E, Roche-Asensio MJ, Rubio-Calvo E, Sánchez-Ortı́z E, Salvador-Oliván JA. Prevalence of diabetes and impaired glucose tolerance in Aragón, Spain. Diabetes Care. 1997;20:534–536
  6. Bayo J, Sola C, Garcı́a F, Latorre PM, Vázquez JA. Prevalencia de la diabetes mellitus no dependiente de la insulina en Lejona (Vizcaya). Med. Clı́n. Barc. 1993;101:609–612
  7. Franch J, Alvarez F, Diego F, Hernández R, Cueto A. Epidemiologı́a de la diabetes mellitus en la provincia de León. Med. Clı́n. Barc. 1998;91:401–405
  8. Castell C, Tresserras R, Serra J, Goday A, Lloveras G, Salleras L. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res. Clin. Pract. 1999;43:33–40
  9. Muñiz J, Hervada JR, Juane R, López-Rodriguez I, Castro-Boiras A. Prevalence of diabetes mellitus in the population aged 40–69 years in Galicia, Northwest Spain. Diabetes Res. Clin. Pract. 1995;30:137–142
  10. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, WHO Tech. Rep. Ser. no 646, 1980
  11. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1181-1187.
  12. Instituto de Estadı́stica de Andalucı́a: Sistema de información municipal de Andalucı́a. Junta de Andalucı́a, Sevilla, 1996.
  13. Farrer M, Alberts CJ, Neil HA, Adams PC, Laker MF, Alberti KG. Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys. Diab. Med. 1995;12:325–329
  14. American Diabetes Association. Self-monitoring of blood glucose. Diabetes Care. 1995;18:47–52
  15. Lernmark A, Kolb H, Mire-Sluis T. Towards a World Health Organisation (WHO) approved standard sample for islet cell antibodies, GAD65 and IA2 autoantibodies. Diabetologia. 1999;42:381–382
  16. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 1994;43:459–467
  17. Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Radizabeh A, et al. Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type 1 diabetes mellitus. Diabetes. 1987;36:1286–1291
  18. Shmidli RS, Colman PG, Bonifacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the 2nd International GADAb workshop. Diabetes. 1995;44:636–640
  19. O.B. Ahmad, C. Boschi-Pinto, A.D. Lopez, C.J.L. Murray, R. Lozano, M. Inoue. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series: Number 31 EIP/GPE/EBD World Health Organization June 27, 2001 url:http://www-nt.who.int/whosis/statistics/discussion_papers/pdf/paper31.pdf.
  20. Zimmet P, Rowley M, Mackay MJ, Knowles WJ, Chen QY, Chapman LH, et al. The ethnic distribution of antibodies to glutamic acid decarboxylase: presence and levels in insulin-dependent diabetes mellitus in European and Asian subjects. J. Diabetes Complication. 1993;7:1–7
  21. Irvine WJ, Gray RS, McCallum CJ, Duncan LPJ. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetic patients treated with oral hypoglycemic agents. Lancet. 1977;i:1025–1027
  22. Groop L, Bottazzo GF, Doniach D. Islet cell antibodies identify latent type 1 diabetes in patients aged 35–75 years at diagnosis. Diabetes. 1986;35:237–241
  23. Gottsaner A, Landin-Olsson M, Fernlund P, Lernmarck A, Sundkvist G. β-cell function in relation to islet cell antibodies during the first 3 years clinical diagnosis of diabetes in type 2 diabetic patients. Diabetes Care. 1993;16:902–910
  24. Turner R, Stratton I, Horton V, Manley S, Simmet P, Mackay IR, et al. For UK Prospective Diabetes Sudy (UKPDS) Group: UKPDS 25: autoantibodies to islet cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet. 1997;350:1288–1293
  25. Niskanen LK, Tuomi T, Karjalainen J, Groop LC, Uusitupa MIJ. GAD antibodies in NIDDM. Ten years follow-up from the diagnosis. Diabetes Care. 1995;18:1557–1565
  26. Ruige JB, Batsra MR, Aanstroot HJ, Bouter LM, Bruining GJ, de Neeling JN, et al. Low prevalence of antibodies to GAD65 in a 50–74 years-old general Dutch population. Diabetes Care. 1997;20:1108–1110
  27. Pietropaolo M, Hutton JC, Eisenbarth GS. Protein tyrosine phosphatase-like proteins: link with IDDM. Diabetes Care. 1997;20:208–214
  28. Tsuruoka A, Matsuba I, Toyota T, Isshiki G, Nagataki S, Ikeda Y. Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes Res. Clin. Pract. 1995;28:191–199
  29. Dowse GK, Zimmet PZ, Spark RA, Mavo B, Rowley MJ, McCaley IR. Lack of antibodies to glutamic acid decarboxylase in young adults of the high diabetic prevalence Waniela people of Papua New Guinea. Diabetes Res. Clin. Pract. 1994;24:195–198
  30. Rowley MJ, Mchay IR, Chen QY, Knowles WJ, Zimmet PZ. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes. 1992;41:548–551
  31. Zimmet PZ, Shaten BJ, Kuller LH, Rowley MJ, Knowles WJ, Mchay IR. Antibodies to glutamic acid decarboxylase as predictors of insulin dependent diabetes mellitus before clinical onset of diabetes. Lancet. 1994;343:1383–1385
  32. Orchard TJ. From diagnosis and classification to complications and therapy. Diabetes Care. 1994;17:326–338
  33. Bosi E, Garancini MP, Poggiali F, Bonifacio E, Gallus G. Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy. Diabetologia. 1999;42:840–844
  34. Rolandsson O, Hägg E, Hampe C, Sullivan EP, Nilsson M, Jansson G, et al. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) antoantibodies index in a general population is related to glucose intolerance and body mass index. Diabetologia. 1999;42:555–559
  35. McCance DR, Hanson RL, Pettitt DJ, Bennett PH, Hadden DR, Knowler WC. Diagnosing diabetes mellitus: do we need new criteria?. Diabetologia. 1997;40:247–255
  36. Olveira G, Soriguer F, Vázquez F, González-Romero S, Ruiz de Adana MS, Aguilar M. Tendencias en la prescripción de medicamentos antidiabéticos en Andalucı́a (1986–1994). Aten. Primaria. 1999;24:145–150
  37. Papazoglou N, Manes CH, Chatzimitrofanus P. Epidemiology of diabetes mellitus in the elderly in Northern Greece: a population study. Diabetic Med. 1997;12:397–410
  38. Harris M. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care. 1993;16:642–652
  39. Guerrero F, Ortego J, Córdoba JA, Girón JA, Aguilar-Diosdado M. Clinical parameters (body mass index and age) are the best predictors for need of insulin therapy during the first 18 months of diabetes mellitus in young adult patients. Horm. Metab. Res. 2000;32:185–189

PII: S0168-8227(02)00002-5

Diabetes Research and Clinical Practice
Volume 56, Issue 3 , Pages 213-220 , June 2002

Article Tools